The presence and significance of Leishmania in mucocutaneous biopsies from HIV+ patients with visceral leishmaniasis

European Journal of Dermatology

Volumn 6, Issue 7, 1996, Pages 501-504

  Herrera, Enrique ^a   Bosch, Ricardo Juan ^a   Fernandez, Francisco ^a   De Troya, Magdalena ^a   Sanchez, Purificación ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Human immunodeficiency virus infection; Leishman bodies; Skin biopsies; Visceral leishmaniasis

Indexed keywords

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LEISHMANIA; LEISHMANIASIS; MALE;

EID: 0029854048     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Alvar J, Gutierrez Solar B, Molina R, et al. Prevalence of leishmaniasis infection among AIDS patients. Lancet 1992; 339: 1427.
2. Alvar J. Leishmaniasis and AIDS co-infection. The Spanish example. Parasitol Today 1994; 10: 160-3.
3. World Health Organisation. AIDS, leishmaniasis dangers of clash highlighted. TDR News 1991; 36: 1.
4. Montalban C, Martinez-Fernández R, Calleja JL, et al. Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. Rev Infect Dis 1989; 11: 655-60.
5. Dover JS, Johnson RA. Cutaneous manifestations of human immunodeficiency virus infection. Part II. Arch Dermatol 1991; 127: 1549-57.
6. Yebra M, Segovia J, Montalban C, Vargas JA. ¿Es el Kala-azar criterio diagnóstico de Síndrome de inmunodeficiencia adquirida? Med Clin (Barc) 1989; 93: 16.
7. Berenguer J, Moreno S, Cercenedo E, et al. Visceral leishmaniasis in patients infected with the human immunodeficiency virus. Ann intern Med 1989; 111: 129-32.
8. Belaich S, Bouscarat F, Picard C. Leishmaniasis and AIDS. In: Burgdorf WHC, Katz SI, eds. Dermatology, Progress and Perspectives. New York: The Parthenon Publishing Group, 1993; 407-9.
9. Imhof M, Schöfer H, Milbradt R, Lutz TH. Mucocutaneous leishmaniasis in an European HIV-positive patient. Eur. J Dermatol 1995; 5: 594-6.
10. Herrera E, Sánchez P, Bosch RJ. Disseminated cutaneous leishmaniasis in an HIV-infected patient. Int J STD & AIDS 1995; 6: 125-6.
11. Jimenez M, Alvar J. Could infected drug-users be potential Leishmania infantum reservoirs? AIDS 1994; 8: 854.
12. Romeu J, Sierra G, Ferrándiz C, et al. Visceral leishmaniasis involving lung and cutaneous Kaposi's sarcoma lesion. AIDS 1991; 5: 1272.
13. Taillan B, Marty P, Schneider S, et al. Visceral leishmaniasis involving a cutaneous Kaposi's sarcoma lesion and free areas of skin. Eur J Med 1992; 4: 255.
14. España A, Hermida JM, Montilla P, Buzon L. Cutaneous and systemic leishmaniasis with herpes virus infection in an AIDS patient (letter). Rev Clin Esp 1990; 187 (8): 437.
15. Magill AJ. Epidemiology of leishmaniasis. Dermatol Clin 1995; 13: 505-23.
16. Martinez R, Garcĩa JD, Gutierrez J, et al. Leishmaniasis visceral en pacientes adictos a drogas vĩa parenteral VIH positivos. Med Clin (Barc) 1987; 88: 509-11.
17. Condom MJ, Clotet B, Sierra G, et al. Asymptomatic leishmaniasis in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989;11:767-8.
18. Montera M, Torre-Cisneros J, Villanueva JL, et al. Leishmania esophagitis in an AIDS patient: an unusual form of visceral leishmaniasis. Am J Gastroenterol 1994; 89: 273-5.
19. Pearson RD, Betts RF. Acquired immunodeficiency syndrome-related visceral leishmaniasis presenting in a pleural effusion. Chest 1993; 103: 648-9.
20. Yebra M, Segovia J, Manzano L, Vargas J, De Quirós LB. Disseminated-to-skin kala-azar and the acquired immunodeficiency syndrome. Ann Intern Med 1988; 108: 490-1.
21. Lustig V, Meenhorst PL, Kager PA. Treatment of visceral leishmaniasis in a patient with AIDS with antimony and GG-inferferon. Remission and prevention of relapse by maintenance therapy with weekly pentamidine. Neth J Med 1995; 47: 66-9.
22. Bryceson ADM, Hay RJ. Parasite worms and protozoa. In: Champion RJ, Burton JL, Ebling FJG, eds. Textbook of Dermatology, 5th ed. London: Blackwell Scientific Publications, 1992; 1260-3.
23. Alarcón R, García E, Dauden E, et al. Leishmaniasis cutánea post kalaazar en un paciente con inmunodeficiencia adquirida. Actas Dermo Sif 1987; 78: 475-7.
24. Ramesh V, Mukherjee A. Post-kala-azar dermal leishmaniasis. Int J Dermatol 1995; 34: 85-91.
25. Molina I, Ramón D, Jorda E, et al. Leishmaniasis con diseminación cutánea en el curso de un Síndrome de Inmunodeficiencia Adquirida. Actas Dermo Sif 1990; 81: 669-71.
26. Perrin C, Taillan B, Hofman P, et al. Atypical cutaneous histological features of visceral leishmaniasis in acquired immunodeficiency syndrome. Am J Dermopathol 1995; 17: 145-50.
27. Magill AJ, Grogl M, Gasser RA, et al. Viscerotropic leishmaniasis caused by Leishmania tropica in soldiers returning from Operation Desert Storm. In: Burgdort WHC, Katz SI, eds. Dermatology progress and perspectives. Proceedings of the 18th World Congress of Dermatology. New York: The Parthenon Publishing Group, 1993; 405-6.
28. Da Cruz AM, Machado ES, Menezes JA, et al. Cellular and humoral immune responses of a patient with American cutaneous leishmaniasis and AIDS. Trans R Soc Trop Med Hyg 1992; 86: A511-2
29. Raccurt CP, Cnudde F, Nicolas M, et al. Diffuse cutaneous leishmaniasis with visceral dissemination in a Haitian suffering from AIDS. Nouv Dermatol 1995; 14: 61-4.